Apollo Care Semaglutide Recall Due to Particulate Matter
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Apollo Care, LLC is recalling 250 vials of semaglutide compounded with glycine due to the presence of particulate matter.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 25, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Drugs.
What Happened Apollo Care, LLC has initiated a voluntary recall of a compounded drug product due to the presence of particulate matter identified as nylon/polyamide and silk/proteinaceous-type material.
Which Products Are Affected The recall involves SEMAGLUTIDE 5mg (1mg/mL), Glycine 25 mg (5mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, distributed under NDC 71170-712-03. Affected product is from Lot AC-017272 with expiration date 12/12/2026. A total of 250 vials were distributed nationwide within the U.S.
What You Should Do Consumers in possession of the recalled product should follow guidance from the recalling firm.
Why This Matters The recall affects a compounded injectable medication distributed across the United States.
Source FDA recall D-0754-2026, Apollo Care, LLC, Columbia, MO.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (856 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to August 25, 2026.
Frequently Asked Questions
Common questions about this FDA recall.